Instil Bio, Inc. (TIL)
7.15
+0.01
(+0.14%)
USD |
NASDAQ |
Sep 30, 16:00
7.15
0.00 (0.00%)
After-Hours: 19:28
Instil Bio EPS Diluted (Quarterly) : -0.6339 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6339 |
| March 31, 2026 | -0.6199 |
| December 31, 2025 | -1.208 |
| September 30, 2025 | -2.011 |
| June 30, 2025 | -3.243 |
| March 31, 2025 | -4.317 |
| December 31, 2024 | -1.823 |
| September 30, 2024 | -3.538 |
| June 30, 2024 | -2.294 |
| March 31, 2024 | -3.736 |
| December 31, 2023 | -1.987 |
| September 30, 2023 | -10.37 |
| June 30, 2023 | -2.869 |
| Date | Value |
|---|---|
| March 31, 2023 | -8.774 |
| December 31, 2022 | -8.292 |
| September 30, 2022 | -8.671 |
| June 30, 2022 | -9.12 |
| March 31, 2022 | -8.382 |
| December 31, 2021 | -8.580 |
| September 30, 2021 | -6.675 |
| June 30, 2021 | -5.485 |
| March 31, 2021 | -3.593 |
| December 31, 2020 | -2.681 |
| September 30, 2020 | -1.127 |
| June 30, 2020 | -1.435 |
| March 31, 2020 | -4.856 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.299M |
| Total Expenses (Quarterly) | 4.299M |
| Enterprise Value | 65.91M |
| Earnings Yield | -62.55% |
| Normalized Earnings Yield | -63.19 |